novo nordisk aspect：Novo
Novo
2023年4月12日—NovoNordiskpens$2.6BdealwithAspectBiosystemsfor3D-printedtissuetreatmentsfordiabetes·Related·Related·AttendEvents.。其他文章還包含有：「AspectandNovoNordiskworkingonbioprintedtissue」、「AspectBiosystemsandNovoNordiskenterpartnershipto...」、「NovoNordiskandAspectjoinforcesforbioprintingtissue...」、「Partnerships」、「ThecollaborationwillleverageAspect's...」
查看更多 離開網站
Aspect and Novo Nordisk working on bioprinted tissue
https://www.labiotech.eu
Aspect and Novo Nordisk are to collaborate on developing bioprinted tissue therapeutics to treat diabetes and obesity.
Aspect Biosystems and Novo Nordisk enter partnership to ...
https://www.aspectbiosystems.c
Under the terms of the agreement, Novo Nordisk will receive an exclusive, worldwide licence to use Aspect's bioprinting technology to develop up ...
Novo Nordisk and Aspect join forces for bioprinting tissue ...
https://www.pharmaceutical-tec
Novo Nordisk and Aspect enter a $725 million partnership to produce pancreatic tissue stem cells for diabetes treatment.
Partnerships
https://aspectbiosystems.com
Aspect Biosystems & Novo Nordisk ... Aspect Biosystems and Novo Nordisk are partnering to develop bioprinted tissue therapeutics designed to replace, repair, or ...
The collaboration will leverage Aspect's ...
https://www.novonordisk.com
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity.